Home > PHILTRE annual report 2021/22.

WEDINOS. (2022) PHILTRE annual report 2021/22. Cardiff: WEDINOS.

[img]
Preview
PDF (WEDINOS 2021/22)
4MB

WEDINOS is funded by Welsh Government and was launched in October 2013 as a collaboration between Public Health Wales, Cardiff Toxicology Laboratories at University Hospital Llandough, Cardiff and Vale University Health Board and the School of Pharmacy at Cardiff University. WEDINOS provides a framework for the collection and testing of samples of psychoactive substances and combinations of drugs (hereafter referred to as “samples”) along with information on the symptoms that those submitting samples experienced, both expected and unexpected. Collation of these findings along with identification of the chemical structure of the samples enables the dissemination of pragmatic evidence-based harm reduction information for those using psychoactive drugs or considering use. The analytical tools used for the profiling of samples includes a Quadrupole Time of Flight (Q-ToF) mass spectrometer (the primary analytical tool), a Fourier-Transform Infrared (FTIR) spectrometer, Nuclear Magnetic Resonance (NMR) spectroscopy, Gas Chromatography–Mass Spectrometry (GC-MS) and Liquid Chromatography–Mass Spectrometry (LC-MS).

Total to date:
27,286 samples received
• 23,249 analysed
• 641 substances identified either in isolation of combination.
• From 297 different organisations, services and night time economy (NTE) venues (night club amnesty bins) from across the UK.

This Year 2021/22:
• 7,457 samples received representing a increase of 92.6 percent from 2020/21.
• 6,345 analysed 85.7 percent.
• Community samples increased by 59.5 percent to 4,684.
• 181 substances identified 14.6 percent.

Item Type
Report
Publication Type
International, Report
Drug Type
Substances (not alcohol/tobacco)
Intervention Type
Screening / Assessment
Date
August 2022
Pages
24 p.
Publisher
WEDINOS
Corporate Creators
WEDINOS
Place of Publication
Cardiff
EndNote

Repository Staff Only: item control page